What dose do you typically use when retreating locally aggressive and recurrent SCCs of the scalp (with no regional or distant mets)?
Assume all other options have been exhausted or are not feasible (e.g. systemic treatments, medically inoperable, etc.). Is there a BED or EQD2 that you aim for in terms of offering durable control?
Answer from: Radiation Oncologist at Academic Institution
Not much great data to support this contention, but my general practice is EQD2 of 70-80 Gy in a continuous course using shrinking field technique, depending on prior radiotherapy and tolerance of nearby organs at risk. For gross disease, concurrent systemic therapy may be worthwhile in patien...